Mario Kahn

机构：Yale University, Gastroenterology Center of Connecticut, Clinics Hospital of Ribeirão Preto

发表论文 66 篇 · 总被引 4008 次 · h-index 27

代表论文

• Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis (2023 · Proceedings of the National Academy of Sciences · 被引 61)
• SGLT2 inhibition alters substrate utilization and mitochondrial redox in healthy and failing rat hearts (2024 · Journal of Clinical Investigation · 被引 47)
• Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction–associated steatohepatitis (2025 · Proceedings of the National Academy of Sciences · 被引 37)
• Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCε-insulin receptorT1150 phosphorylation pathway (2024 · Cell Reports · 被引 28)
• Distinct subcellular localisation of intramyocellular lipids and reduced PKCε/PKCθ activity preserve muscle insulin sensitivity in exercise-trained mice (2022 · Diabetologia · 被引 27)
• Cytosolic calcium regulates hepatic mitochondrial oxidation, intrahepatic lipolysis, and gluconeogenesis via CAMKII activation (2024 · Cell Metabolism · 被引 24)